1887

Abstract

Group B streptococci (GBS) are pathogens of both neonates and adults, with serotype III strains in particular being associated with invasive disease and meningitis. In this study, a novel GBS surface antigen, , was found to be co-expressed with the previously reported antigen on an identical subset of serotype III GBS. Expression of / on the surface of serotype III GBS was shown to distinguish the restriction digest pattern (RDP) III-3 and multilocus sequence typing (ST)-17 lineage. -Specific antibodies were reactive with a unique, high-molecular-mass, serine-rich repeat protein (Srr-2) found exclusively in RDP III-3 strains. The gene encoding Srr-2 was located within a putative accessory secretory locus that included and homologues and had a genetic organization similar to that of the / locus of staphylococci. In contrast, serotype III /-negative strains and strains representative of serotypes Ia, Ib, Ic and II shared a common Srr-encoding gene, , and an organization of the / locus similar to that of previously reported serotype Ic, /-negative serotype III and serotype V GBS strains. Representative serotype III /-positive strains had LD values 3–4 logs less than those of serotype III /-negative strains in a neonatal mouse model of infection. These results indicate that the RDP III-3/ST-17 lineage expresses Srr-2 and is highly virulent in an model of neonatal sepsis.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.28516-0
2006-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/micro/152/4/1029.html?itemId=/content/journal/micro/10.1099/mic.0.28516-0&mimeType=html&fmt=ahah

References

  1. Adderson E. E, Takahashi S, Wang Y, Armstrong J, Miller D. V, Bohnsack J. F. 2003; Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae . Infect Immun 71:6857–6863 [CrossRef]
    [Google Scholar]
  2. Areschoug T, Stalhammar-Carlemalm M, Karlsson I, Lindahl G. 2002; Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc. J Biol Chem 277:12642–12648 [CrossRef]
    [Google Scholar]
  3. Auperin T. C, Bolduc G. R, Baron M. J, Heroux A, Filman D. J, Madoff L. C, Hogle J. M. 2005; Crystal structure of the N-terminal domain of the group B Streptococcus alpha C protein. J Biol Chem 280:18245–18252 [CrossRef]
    [Google Scholar]
  4. Baker C. J, Edwards M. S. 2001; Group B streptococcal infections. In Infectious Diseases of the Fetus and Newborn Infant pp.  1091–1156 Edited by Remington J. S., Klein J. O. Philadelphia, PA: W. B. Saunders;
    [Google Scholar]
  5. Bensing B. A, Sullam P. M. 2002; An accessory sec locus of Streptococcus gordonii is required for export of the surface protein GspB and for normal levels of binding to human platelets. Mol Microbiol 44:1081–1094 [CrossRef]
    [Google Scholar]
  6. Bensing B. A, Lopez J. A, Sullam P. M. 2004; The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect Immun 72:6528–6537 [CrossRef]
    [Google Scholar]
  7. Bevanger L. 1985; The Ibc proteins of group B streptococci: isolation of the alpha and beta antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand Sect B Microbiol 93:113–119
    [Google Scholar]
  8. Bisharat N, Crook D. W, Leigh J, Harding R. M, Ward P. N, Coffey T. J, Maiden M. C, Peto T, Jones N. 2004; Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol 42:2161–2167 [CrossRef]
    [Google Scholar]
  9. Bohnsack J. F, Takahashi S, Detrick S. R, Pelinka L. R, Hammitt L. L, Aly A. A, Whiting A. A, Adderson E. E. 2001; Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. J Infect Dis 183:1694–1697 [CrossRef]
    [Google Scholar]
  10. Bohnsack J. F, Whiting A. A, Bradford R. D, Van Frank B. K, Takahashi S, Adderson E. E. 2002; Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun 70:134–139 [CrossRef]
    [Google Scholar]
  11. Boyer K. M, Gadzala C. A, Kelly P. D, Burd L. I, Gotoff S. P. 1983; Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 148:802–809 [CrossRef]
    [Google Scholar]
  12. Brady L. J, Daphtary U. D, Ayoub E. M, Boyle M. D. 1988; Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis 158:965–972 [CrossRef]
    [Google Scholar]
  13. Brady L. J, Hofig A, Addison M. N, Lim D. V. 1996 Association of two antigens, delta and epsilon, with pathogenic serotype III group B streptococci. Proceedings of the 96th General Meeting of the American Society for Microbiology , abstract no. B-350 Washington, DC: American Society for Microbiology;
    [Google Scholar]
  14. Chen Q, Wu H, Fives-Taylor P. M. 2002; Construction of a novel transposon mutagenesis system useful in the isolation of Streptococcus parasanguis mutants defective in Fap1 glycosylation. Infect Immun 70:6534–6540 [CrossRef]
    [Google Scholar]
  15. Chun C. S, Brady L. J, Boyle M. D, Dillon H. C, Ayoub E. M. 1991; Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis 163:786–791 [CrossRef]
    [Google Scholar]
  16. Cleat P. H, Timmis K. N. 1987; Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen. Infect Immun 55:1151–1155
    [Google Scholar]
  17. Davies H. D, Jones N, Whittam T. S, Elsayed S, Bisharat N, Baker C. J. 2004; Multilocus sequence typing of serotype III streptococcus and correlation with pathogenic potential. J Infect Dis 189:1097–1102 [CrossRef]
    [Google Scholar]
  18. Farley M. M. 2001; Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33:556–561 [CrossRef]
    [Google Scholar]
  19. Ferrieri P. 1985; GBS infections in the newborn infant: diagnosis and treatment. Antibiot Chemother 35:211–224
    [Google Scholar]
  20. Fischetti V. A, Pancholi V, Schneewind O. 1990; Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mol Microbiol 4:1603–1605 [CrossRef]
    [Google Scholar]
  21. Fleming K. E, Bohnsack J. F, Palacios G. C, Takahashi S, Adderson E. E. 2004; Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS). J Med Microbiol 53:505–508 [CrossRef]
    [Google Scholar]
  22. Glaser P, Rusniok C, Buchrieser C. 9 other authors 2002; Genome sequence of Streptococcus agalactiae , a pathogen causing invasive neonatal disease. Mol Microbiol 45:1499–1513 [CrossRef]
    [Google Scholar]
  23. Gravekamp C, Horensky D. S, Michel J. L, Madoff L. C. 1996; Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect Immun 64:3576–3583
    [Google Scholar]
  24. Handley P. S, Correia F. F, Russell K, Rosan B, DiRienzo J. M. 2005; Association of a novel high molecular weight, serine-rich protein (SrpA) with fibril-mediated adhesion of the oral biofilm bacterium Streptococcus cristatus . Oral Microbiol Immunol 20:131–140 [CrossRef]
    [Google Scholar]
  25. Héry-Arnaud G, Bruant G, Lanotte P, Brun S, Rosenau A, Quentin R, Mereghetti L, van der Mee-Marquet N. 2005; Acquisition of insertion sequences and the GBSi1 intron by Streptococcus agalactiae isolates correlates with the evolution of the species. J Bacteriol 187:6248–6252 [CrossRef]
    [Google Scholar]
  26. Johnson D. R, Ferrieri P. 1984; Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 19:506–510
    [Google Scholar]
  27. Jones N, Bohnsack J. F, Takahashi S. 9 other authors 2003; Multilocus sequence typing for group B streptococcus. J Clin Microbiol 41:2530–2536 [CrossRef]
    [Google Scholar]
  28. Kremer B. H, Crowley P. J, Hamilton I. R, Brady L. J, Bleiweis A. S, van der Kraan M. 2001; Characterization of the sat operon in Streptococcus mutans : evidence for a role of Ffh in acid tolerance. J Bacteriol 183:2543–2552 [CrossRef]
    [Google Scholar]
  29. Law M. R, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, Reid T, Schrag S. 2005; The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen 12:60–68 [CrossRef]
    [Google Scholar]
  30. Lindahl G, Stalhammar-Carlemalm M, Areschoug T. 2005; Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18:102–127 [CrossRef]
    [Google Scholar]
  31. Luan S. L, Granlund M, Sellin M, Lagergard T, Spratt B. G, Norgren M. 2005; Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 43:3727–3733 [CrossRef]
    [Google Scholar]
  32. Maeland J. A, Brakstad O. G, Bevanger L, Kvam A. I. 1997; Streptococcus agalactiae beta gene and gene product variations. J Med Microbiol 46:999–1005 [CrossRef]
    [Google Scholar]
  33. Maione D, Margarit I, Rinaudo C. D. 24 other authors 2005; Identification of a universal Group B Streptococcus vaccine by multiple genome screen. Science 309:148–150 [CrossRef]
    [Google Scholar]
  34. Martin T. R, Rubens C. E, Wilson C. B. 1988; Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 157:91–100 [CrossRef]
    [Google Scholar]
  35. Michel J. L, Madoff L. C, Kling D. E, Kasper D. L, Ausubel F. M. 1991; Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 59:2023–2028
    [Google Scholar]
  36. Michon F, Brisson J. R, Dell A, Kasper D. L, Jennings H. J. 1988; Multiantennary group-specific polysaccharide of group B Streptococcus . Biochemistry 27:5341–5351 [CrossRef]
    [Google Scholar]
  37. Musser J. M, Mattingly S. J, Quentin R, Goudeau A, Selander R. K. 1989; Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 86:4731–4735 [CrossRef]
    [Google Scholar]
  38. Nagano Y, Nagano N, Takahashi S, Murono K, Fujita K, Taguchi F, Okuwaki Y. 1991; Restriction endonuclease digest patterns of chromosomal DNA from group B beta-haemolytic streptococci. J Med Microbiol 35:297–303 [CrossRef]
    [Google Scholar]
  39. Puopolo K. M, Madoff L. C, Eichenwald E. C. 2005; Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115:1240–1246 [CrossRef]
    [Google Scholar]
  40. Reed L. J, Muench M. H. 1938; A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497
    [Google Scholar]
  41. Rodewald A. K, Onderdonk A. B, Warren H. B, Kasper D. L. 1992; Neonatal mouse model of group B streptococcal infection. J Infect Dis 166:635–639 [CrossRef]
    [Google Scholar]
  42. Rubens C. E, Heggen L. 1988; Tn 916 ΔE: a Tn 916 derivative expressing erythromycin resistance. Plasmid 20:137–142 [CrossRef]
    [Google Scholar]
  43. Russell-Jones G. J, Gotschlich E. C. 1984; Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med 160:1476–1484 [CrossRef]
    [Google Scholar]
  44. Sambrook J, Fritsch E. F, Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  45. Schrag S. J, Zywicki S, Farley M. M. 7 other authors 2000; Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20 [CrossRef]
    [Google Scholar]
  46. Seifert K. N, McArthur W. P, Bleiweis A. S, Brady L. J. 2003; Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can J Microbiol 49:350–356 [CrossRef]
    [Google Scholar]
  47. Siboo I. R, Chambers H. F, Sullam P. M. 2005; Role of SraP, a serine-rich surface protein of Staphylococcus aureus , in binding to human platelets. Infect Immun 73:2273–2280 [CrossRef]
    [Google Scholar]
  48. Staden R. 1996; The Staden sequence analysis package. Mol Biotechnol 5:233–241 [CrossRef]
    [Google Scholar]
  49. Stalhammar-Carlemalm M, Stenberg L, Lindahl G. 1993; Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 177:1593–1603 [CrossRef]
    [Google Scholar]
  50. Stephenson A. E, Wu H, Novak J, Tomana M, Mintz K, Fives-Taylor P. 2002; The Fap1 fimbrial adhesin is a glycoprotein: antibodies specific for the glycan moiety block the adhesion of Streptococcus parasanguis in an in vitro tooth model. Mol Microbiol 43:147–157 [CrossRef]
    [Google Scholar]
  51. Takahashi S, Adderson E. E, Nagano Y, Nagano N, Briesacher M. R, Bohnsack J. F. 1998; Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis 177:1116–1119 [CrossRef]
    [Google Scholar]
  52. Takahashi Y, Konishi K, Cisar J. O, Yoshikawa M. 2002; Identification and characterization of hsa , the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect Immun 70:1209–1218 [CrossRef]
    [Google Scholar]
  53. Takahashi Y, Yajima A, Cisar J. O, Konishi K. 2004; Functional analysis of the Streptococcus gordonii DL1 sialic acid-binding adhesin and its essential role in bacterial binding to platelets. Infect Immun 72:3876–3882 [CrossRef]
    [Google Scholar]
  54. Takamatsu D, Bensing B. A, Sullam P. M. 2004a; Four proteins encoded in the gspB-secY2A2 operon of Streptococcus gordonii mediate the intracellular glycosylation of the platelet-binding protein GspB. J Bacteriol 186:7100–7111 [CrossRef]
    [Google Scholar]
  55. Takamatsu D, Bensing B. A, Sullam P. M. 2004b; Genes in the accessory sec locus of Streptococcus gordonii have three functionally distinct effects on the expression of the platelet-binding protein GspB. Mol Microbiol 52:189–203 [CrossRef]
    [Google Scholar]
  56. Tettelin H, Masignani V, Cieslewicz M. J. 40 other authors 2002; Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae . Proc Natl Acad Sci U S A 99:12391–12396 [CrossRef]
    [Google Scholar]
  57. Tettelin H, Masignani V, Cieslewicz M. J. 43 other authors 2005; Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae : implications for the microbial “pan-genome”. Proc Natl Acad Sci U S A 102:13950–13955 [CrossRef]
    [Google Scholar]
  58. Tyrrell G. J, Senzilet L. D, Spika J. S, Kertesz D. A, Alagaratnam M, Lovgren M, Talbot J. A. 2000; Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study –1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 182:168–173 [CrossRef]
    [Google Scholar]
  59. Ustinovitch I, Vlasov G, Totolyan A, Suvorov A. 1999; Cloning and expression of gene fragment IgA-binding protein of group B streptococci. Folia Microbiol (Praha) 44:726–728 [CrossRef]
    [Google Scholar]
  60. Wilkinson H. W, Eagon R. G. 1971; Type-specific antigens of group B type Ic streptococci. Infect Immun 4:596–604
    [Google Scholar]
  61. Wu H, Fives-Taylor P. M. 1999; Identification of dipeptide repeats and a cell wall sorting signal in the fimbriae-associated adhesin, Fap1, of Streptococcus parasanguis . Mol Microbiol 34:1070–1081 [CrossRef]
    [Google Scholar]
  62. Wu H, Mintz K. P, Ladha M, Fives-Taylor P. M. 1998; Isolation and characterization of Fap1, a fimbriae-associated adhesin of Streptococcus parasanguis FW213. Mol Microbiol 28:487–500 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.28516-0
Loading
/content/journal/micro/10.1099/mic.0.28516-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error